At Children’s Hospital of Philadelphia, we know innovation sometimes requires a second look at seemingly harmless practices and a willingness to break out of the status quo. In this edition of In the News, learn how an unnecessary emergency room visit prompted Christopher Bonafide, MD, to examine the use of physiological monitors for healthy infants, and read about a bold move toward future innovation with the grand opening of our new Clinical Manufacturing Facility for precision medical tools. Additionally, the Center for Child Injury and Prevention Studies’ Annual Report highlights important safety work with real-world implications, a new Penn-CHOP collaboration aims to investigate nutritional interventions to treat disease, and a CHOP patient gets the surprise of a lifetime in the name of autism awareness.
Category Archive: Children's Hospital of Philadelphia Research Institute
With an enterprising career spanning 50 years in basic and clinical immunology and more than 500 publications, Steven D. Douglas, MD, had the honor of presenting the 25th Herman and Gertrude Silver Lecture, in which he reviewed major milestones in the field of pediatric HIV/AIDS and shared his optimism that paradigm shifts and new discoveries are ahead.
Researchers have published best practice recommendations for nasogastric (NG) tube location placement and verification in pediatric patients. Endorsed by the American Society for Parental and Enteral Nutrition (ASPEN), the recommendations include: provide education; use appropriate NGT placement and securing methods; measure gastric pH; consider a radiograph for any patient in whom there is a concern for correct NGT placement; and improve interpretation and communication about the radiograph.
Why it matters:
Upto this point, no standard for the NG tube insertion procedure existed in the United States. If performed improperly, the common practice has potentially serious or fatal complications, including tubes being placed in the child’s lung or snaking into the brain. In addition, the tube can be inserted into the small intestine rather than the intended target of the stomach.
Fall weather and football season have returned to us here at Children’s Hospital of Philadelphia Research Institute, bringing with them a fresh batch of research headlines. In this edition of our biweekly news roundup, catch up on the latest announcements for the second annual Eagles Autism Challenge, learn about new insights into the role mitochondrial DNA plays in heart disease progression, and stay updated on how CHOP helps to drive medical innovation and entrepreneurship forward in the Philadelphia community and beyond.
Six students from local under-resourced schools eagerly swapped sunglasses for safety goggles and got to work this summer in some of the most sophisticated research laboratories on campus at Children’s Hospital of Philadelphia Research Institute.
The students navigated real-world research settings, practiced lab skills, explored scientific and medical career options, and met mentors who are dedicated to advancing pediatric medicine, as part of the six-week CHOP Research Internship for Scholars and Emerging Scientists (CHOP-RISES) summer internship. The new program is offered by the Office of Academic Training and Outreach Programs (ATOP) at the Research Institute.
It’s still a month before teachers and students are officially back to school, but here at Children’s Hospital of Philadelphia Research Institute, you can learn something new every day. In this edition of our biweekly news roundup, discover the latest findings from our ophthalmologists on how clinicians should choose to screen premature babies for a potentially blinding eye disorder, find out how CRISPR-based technology allowed scientists to reveal insights into sickle cell disease, and prepare for an educational and exciting speech from the recently announced keynote speaker at PolicyLab’s upcoming 10th Anniversary Forum
Editor’s Note: Families facing a rare disease diagnosis often do not know where to turn first in their search for the most advanced treatments and potentially a cure for their children. Only 5 percent of rare diseases have a treatment approved by the Food and Drug Administration, according to the National Organization for Rare Disorders. This is due in part to the lack of high quality biospecimens for research.
A new year brings new beginnings, and in 2018 the Research Institute is welcoming Richard Aplenc, MD, PhD, MSCE, to his new role as assistant vice president and chief clinical research officer. While Dr. Aplenc is new to the Research Institute’s leadership team, his more than two decades of experience at CHOP started with his Pediatric Hematology Oncology fellowship in 1997. Dr. Aplenc joined the faculty in 2002 and is currently a professor of Pediatrics as well as a professor of Epidemiology. In his new role, Dr. Aplenc will set the course for the development and oversight of clinical research operations across Children’s Hospital of Philadelphia. It’s a position that offers big challenges — and even bigger opportunities.